Background {#Sec1}
==========

Mesiodens is the most common supernumerary teeth located in the central position of the upper or lower jaw \[[@CR1]\]. Mesiodens can be either erupted or impacted in alveolar bone placed and oriented vertically, horizontally or in an inverted manner \[[@CR2], [@CR3]\]. The prevalence of mesiodens in the population ranges from 0.09 to 2.2%, according to previous studies \[[@CR4]--[@CR6]\]. A series of clinical complications can be caused by mesiodens, including malposition or delayed eruption of the permanent incisors or the formation of a dentigerous cyst \[[@CR7]--[@CR9]\]. However, the etiology of mesiodens is still unclear.

An increasing number of studies indicate that genetic polymorphisms are associated with oral diseases. For instance, in Polish children, the prevalence of the AG genotype of the Enamelin (*ENAM*) gene (rs12640848) was higher in subjects with dental caries compared to that in controls \[[@CR10]\]. The polymorphism of COX2 -765G/C had significant influence on periodontitis risk \[[@CR11]\]. The genetic polymorphism of axin 2 (*AXIN2*) and Gremiln-2 (*GREM2*, also called *PRDC*) were related with tooth agenesis \[[@CR12], [@CR13]\].

Studies have shown that several genes can result in the formation of mesiodens. The Paired box gene 6 (*PAX6*) mutant in rats can result in the formation of a supernumerary upper incisor \[[@CR14]\]. The inactivation of Family with sequence similarity member 20-B (*FAM20B*) in the dental epithelium in mice results in supernumerary maxillary and mandibular incisors \[[@CR15]\]. The deletion of Sclerostin domain-containing 1 (*SOSTDC 1*, also known as *Wise*, Ectodin, or *USAG-1*) in mice leads to the development of extra molar and incisors \[[@CR16], [@CR17]\]. However, research regarding the association between genetic polymorphism and mesiodens formation has been reported less often. Therefore, the purpose of the current study is to analyze the association between mesiodens formation and the genetic polymorphisms of genes related to this process, identifying the importance of genetic polymorphisms in mesiodens formation-related genes.

Methods {#Sec2}
=======

Study participants {#Sec3}
------------------

One hundred patients (50 mesiodens group, 50 unrelated controls) were recruited in this study in Bengbu, China. The diagnosis of mesiodens was based on oral examination combined with periapical radiograph, panoramic radiograph, and/ or cone-beam computed tomography. The characteristics including gender, crown direction, the number of mesiodens, and the eruption status of mesiodens were recorded. All patients had no abnormalities in their head, ears, eyes, nose, throat, thyroid, trunk, or extremities and were without cleft lip or palate, congenital absence of teeth or tooth malformation. The family history was recorded.

Saliva collection and genomic DNA extraction {#Sec4}
--------------------------------------------

A total of 2 mL of unstimulated saliva sample for each recruited participant was collected and stored using Oragene DNA Self-Collection kits (Lang Fu, Shanghai, China). Genomic DNA was extracted using the MagBeads Saliva & Swab DNA Extraction Kit (Regular & Pre-loading Version, Enriching Biotechnology LTD, Shanghai, China) according to the manufacturer's protocol. The Genomic DNA samples were stored at − 20 °C until further analysis.

Sanger sequencing of selected mesiodens formation related genes {#Sec5}
---------------------------------------------------------------

We were particularly interested in *PAX6*, *SOSTDC1*, and *FAM20B*, which were reported to result in the formation of mesiodens. All exons and exon/intron boundaries of these three genes in 100 samples were amplified using a GC-rich PCR Kit (Sangon Biotech, Shanghai, China) combined with Champagne Taq DNA Polymerase (Vazyme, Nanjing, China). The PCR products were purified using a MagBeads Gel DNA Extraction Kit (Enriching Biotechnology LTD, Shanghai, China) according to the manufacturer's instructions. The PCR reaction mixture (50 μL) included 3 μL of template, 5 μL of buffer, 4 μL of dNTP, 1 μL of each of the specific forward and reverse primers for these three genes, 0.25 μL rTaq enzyme, and RNase-free water. The PCR was performed with the following temperature procedures: denaturation at 94 °C for 5 min, 35 cycles of 30 s at 94 °C, 30 s at 55 °C, and 30 s at 72 °C, with a 10-min extension step at 72 °C. The purified products were used for Sanger sequenced using the ABI Prism 3730 platform (Applied Biosystems™, USA). The primers used for amplification and sequencing are listed in Table [1](#Tab1){ref-type="table"}. The primers of *PAX6* were selected according to previous study \[[@CR18]\]. The amplification sequences were detailed in Additional file [1](#MOESM1){ref-type="media"} and Additional file [2](#MOESM2){ref-type="media"}.Table 1Amplification and sequencing primersIDPrimer sequencesAmplicon size (bp)Sequencing size (bp)*PAX6* exon-1 FCAAACGGACCAATTGCACCA432432*PAX6* exon-1 RGGTTGGTGTGTGAGAGCAATTCTC*PAX6* exon-2 FCAGAGGTCAGGCTTCGCTAA449449*PAX6* exon-2 RTCGCTGGAAGTAGAAAGTTTGG*PAX6* exon-3 FTGACTGAGCCCTAGATGCATGTG466466*PAX6* exon-3 RTCCCCAATCTGTTTCCCCTACAT*PAX6* exon-4 FGAACGGAGATTCTCCTGTCCTA364364*PAX6* exon-4 RCAGTATCGAGAAGAGCCAAGC*PAX6* exon-5 FAGGATGCATTGTGGTTGTCTCCTC405405*PAX6* exon-5 RTGGGGGGGTCCATAATTAGCA*PAX6* exon-6 FTCCAAGTGCTGGACAATCAA707707*PAX6* exon-6 RAGAGGACACAGACTAAGAGACA*PAX6* exon-7 FGGTGTATCTGCAAATCCACCCA470470*PAX6* exon-7 RCAATGTGGTCGATGTGTCCCA*PAX6* exon-8 FAAGGCTGACAGTTACCTTGGGAA398398*PAX6* exon-8 RTCTTCTATGCAAAGGGCCCTG*PAX6* exon-9 FTTGGTTGGAGGTAATGGGAGTG334334*PAX6* exon-9 RTGGCAGCAGAGCATTTAGCAG*PAX6* exon 10--11 FCCTAGAGACAGAGGTGCTTGTA614614*PAX6* exon 10--11 RGCAGACACAGCCAATGAGG*PAX6* exon-12 FAGCTCGAGGCCCAATCTTAGAT436436*PAX6* exon-12 RAGGGACAAGGAAAGCAAGGAGT*PAX6* exon-13 F1CTTTTCCTTTGGATTGGGGTG654--*PAX6* exon-13 R1CACAGATCAAACATCCATCCAGTC*PAX6* exon-13 F2CCTATAAATTTGTATTCCATGTCOnly used for sequencing149*PAX6* exon-13 R2CTTGGCCAGTATTGAGACATATC*SOSTDC1* exon-1 FACAAGTGATGAAGTCCAACTCT550550*SOSTDC1* exon-1 RTGTGAGCTAATGCTACCAGAA*SOSTDC1* exon-2 F1TGAAAGTGTCCCTATACTATCC842842*SOSTDC1* exon-2 R1AACTACAGGATACGTGGAAT*SOSTDC1* exon-2 F2AAATTCCACGTATCCTGTAG800800*SOSTDC1* exon-2 R2CATGTTAGAGGCAACAACA*FAM20B* exon-1 FGTCCTGCTGCTTGGCTGCCTACCTAC832832*FAM20B* exon-1 RCCTTCAGCCGCGACCGCACA*FAM20B* exon-2 FACTGCTGCCATCATTAGGTCC949949*FAM20B* exon-2 RCAGTGGGTTACCAGGTGTTCT*FAM20B* exon-3 FAATCAGGCTTGCTAATGGGTG417417*FAM20B* exon-3 RAGGCCAGAAATGAAATGACCTA*FAM20B* exon-4 FTTAATTTGCTCTGTGGGCTTAG825825*FAM20B* exon-4 RCACCTGCTTTCACCATCACTA*FAM20B* exon 5--6 FAGAGTGAGACTGGGTAGAAAGGA11301130*FAM20B* exon 5--6 RTAGCCAAGAAAGAACGATGTAG*FAM20B* exon −7 FAAGTTCTCCCTTTGGTCTGTG561561*FAM20B* exon-7 RTTTGGGTTATCTGCCTTCAC*FAM20B* exon-8 F1CCATAATTTAACTATTTCCCAGTCG862862*FAM20B* exon-8 R1CCAATCCCAGTATTCATCTATCC*FAM20B* exon-8 F2TGGTGACGGGACAGAGTGGC795795*FAM20B* exon-8 R2CAGTTTGCTTTGTTAATTTGGGAAG*FAM20B* exon-8 F3AATTTCCACCTCTGCCTTTAA793793*FAM20B* exon-8 R3AGATGAGTGGGCACATCAGG*FAM20B* exon-8 F4TGACTTTGCACCTAAGTAAATTCTG735735*FAM20B* exon-8 R4GGTGGCTCATGCCTGTAATC*FAM20B* exon-8 F5CTGAACCCATGATGTTGTATTA666666*FAM20B* exon-8 R5TCTTCCTATTGTCTCCTCCC*FAM20B* exon-8 F6TTTTAAGGCTACTCAGTGTTGTG842842*FAM20B* exon-8 R6CTCCTGGATTCAAGTGATTCTCC*FAM20B* exon-8 F7AGGCAAATCTTGGAGAAAAC764764*FAM20B* exon-8 R7TCTTGAATAATACTCTGAGCAAA*FAM20B* exon-8 F8ATTTCCTGCCCTCCTCCAAC879879*FAM20B* exon-8 R8CTACCTTGTCACCACCCAGA*FAM20B* exon-8 F9TAGTGTAAGGCTGCATTGTGG765765*FAM20B* exon-8 R9CTTGAGGAATTGAAGGGAAA*FAM20B* exon-8 F10CAGCGAATAACTACTGAGCAA514514*FAM20B* exon-8 R10AAGGGAACTGAAATAGGAACCA

Statistics {#Sec6}
----------

The association between susceptibility to mesiodens and the genetic polymorphism of *PAX6*, *SOSTDC1*and *FAM20B* were assessed using IBM SPSS 20.0 software (IBM, Armonk, NY, USA). The data were analyzed using pearson chi-square test with theoretical frequency ≥ 5. For theoretical frequency less than 5 but at least 1 (≤20% cell), the data were analyzed by continuity correction. For the rest, Fisher's Exact test was used. A *P*-value\< 0.05 was considered statistically significant. The relationships between the characteristics of mesiodens and the polymorphisms with *P* value less than 0.05 were further analyzed using the same method described previously.

Results {#Sec7}
=======

Basic characteristics of patients with mesiodens {#Sec8}
------------------------------------------------

Four of the 50 patients with mesiodens (8%) patients had a family history of mesiodens. The basic characterizes of mesiodens are listed in Table [2](#Tab2){ref-type="table"}.Table 2Characteristic of patients with mesiodens, mean ± SD, or n (%)Numbers50Age (years)11.8 ± 9.3Gender Females16 (32.00) Males34 (68.00)Number of mesiodens per patient 135 (70.00) 215 (30.00)Growth status 1 erupted13 (26.00) 1 impacted22 (44.00) 1 erupted and 1 impacted8 (16.00) 2 erupted2 (4.00) 2 impacted5 (10.00)Crown direction 1 vertical13 (26.00) 1 horizontal4 (8.00) 1 inverted17 (34.00) 1 inverted and 1 vertical6 (12.00) 1 horizontal and 1 vertical4 (8.00) 2 vertical4 (8.00) 1 horizontal and 1 inverted1 (2.00) 2 inverted1 (2.00)Family history4 (8.00)Located in maxilla49 (98.00)Located in mandible1 (2.00)

Associations between mesiodens formation and genetic polymorphisms {#Sec9}
------------------------------------------------------------------

Considering the specific role of family history in mesiodens is still unknown, hence, careful family history is record in our study and excluded when we analyzed the association between mesiodens formation and gene polymorphisms. Removing patients with family history, three polymorphisms (rs750093295, rs667773 and rs3026393) were detected in *PAX6*. Two polymorphisms (rs6945425 and rs12699799) were detected in *SOSTDC1*. Twenty-nine polymorphisms (chr1:179025841, rs193196190, rs72707294, rs1024965514, rs745360443, rs778968805, rs2025584, rs140751029, rs9726948, rs16853612, rs9725887, rs9725888, rs4652352, rs147003645, rs72709441, rs4652353, rs4652354, rs56006430, rs3766625, rs3766626, rs775951319, rs16853619, rs2018786, rs16853621, rs188554154, rs530920451, rs9249, rs117216397, rs1220) were detected in FAM20B. Although, the T allele of *FAM20B* (rs3766626) appears to be associated with mesiodens after removing unqualified sequencing results (*P* = 0.051). There were no significant differences of *PAX6*/*SOSTDC1*/*FAM20B* gene polymorphisms between the two groups (Table [3](#Tab3){ref-type="table"}). The distribution on genotype of these markers according to gender, the number of mesiodens, crown direction, and the eruption status are listed in Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}. The T allele of *FAM20B* (rs3766626) was associated with susceptibility to two mesiodens (*P \<* 0.001; OR = 8.333; CI = 2.516--27.600).Table 3The gene polymorphisms in patients with mesiodens and controlsMarkerGene polymorphismMesiodensControls*P* valuers2025584(*FAM20B*)AA/AG/GG4/23/1610/24/150.326A/G31/5544/540.223rs140751029(*FAM20B*)CC/CT40/443/41.000C/T84/490/41.000rs9726948(*FAM20B*)GG/GT41/241/60.270G/T84/288/60.282rs16853612(*FAM20B*)AA/AG/GG23/12/828/16/30.206A/G58/2872/220.171rs9725887(*FAM20B*)CC/CT/TT15/22/614/19/150.146C/T52/3447/490.120rs9725888(*FAM20B*)CT/TT2/416/420.273C/T2/846/900.284rs4652352(*FAM20B*)AA/AC/CC5/15/236/12/300.584A/C25/6124/720.537rs147003645(*FAM20B*)GG/AG43/047/11.000G/A86/095/11.000rs72709441(*FAM20B*)CC/TT/CT22/6/1528/3/170.477C/T59/2773/230.262rs4652353(*FAM20B*)GG/GT/TT6/14/236/12/300.668G/T26/6024/720.430rs4652354(*FAM20B*)CC/CT/TT19/22/118/23/70.146C/T60/2459/370.159rs56006430(*FAM20B*)CC/CG/GG7/15/213/17/290.269C/G29/5723/750.123rs3766626(*FAM20B*)GG/GT/TT16/21/414/19/140.067G/T53/2947/470.051rs3766625(*FAM20B*)AA/AG/GG/CC6/15/20/02/17/27/10.277A/G/C27/55/021/71/20.131rs16853619(*FAM20B*)AG/GG2/396/410.276A/G2/806/880.287rs72707294(*FAM20B*)GG/GC/CC8/18/223/18/270.249G/C34/6224/720.116rs2018786(*FAM20B*)AA/AG/GG7/14/231/18/300.061A/G28/6020/780.076rs16853621(*FAM20B*)AA/AG/GG36/4/140/8/00.361A/G76/688/80.802rs188554154(*FAM20B*)GG/GT43/047/11.000G/T86/095/11.000rs530920451(*FAM20B*)AA/AG43/147/11.000A/G87/195/11.000rs775951319(*FAM20B*)CC4147--rs778968805(*FAM20B*)CC/CT46/046/11.000C/T92/093/11.000rs745360443(*FAM20B*)GG/AG47/149/00.495G/A95/198/00.495rs1024965514(*FAM20B*)CT/CC1/470/481.000C/T95/196/01.000chr1:179025841(*FAM20B*)AA/AG45/142/01.000A/G91/184/01.000rs193196190(*FAM20B*)GG4038--rs9249(*FAM20B*)AA/AG/GG5/16/233/17/280.666A/G26/6223/730.392rs117216397(*FAM20B*)AA/AG42/248/00.226A/G86/296/00.227rs1220(*FAM20B*)AA/AC/CC/GG20/19/4/117/23/8/00.428A/C/G59/27/257/39/00.126rs667773(*PAX6*)CC/CT/TT27/13/236/10/10.451C/T67/1782/120.178rs750093295(*PAX6*)CC/GG/CT41/1/045/0/10.730C/T/G82/0/291/1/00.226rs3026393(*PAX6*)GG/GT/TT6/26/1017/20/100.056G/T38/4654/400.104rs6945425(*SOSTDC1*)AG/GG6/368/380.691A/G6/788/840.704rs12699799(*SOSTDC1*)AA/AG/GG6/23/138/17/220.199A/G35/4933/610.369Table 4The distribution of AA genotype of FAM20B (rs2018786) according to eruption statusgenotype1 erupted1 impacted1 erupted + 1 impacted2 erupted2 impactedAA13003others817822Table 5The distribution of AA genotype of FAM20B (rs2018786) according to crown directiongenotype1 vertical1 horizontal1 inverted1 inverted + 1 vertical1 horizontal + 1 vertical2 vertical1 horizontal+ 1 inverted2 invertedAA20202010others831452401

Discussion {#Sec10}
==========

A total of 8% of patients have a family history of mesiodens, which may indicate that the occurrence of mesiodens is partially determined by genetics. The patients with mesiodens were mostly concentrated in the northern and southern regions of Bengbu. The occurrence of mesiodens might have regional distribution characteristics.

*PAX6* is an important gene involved in a series of diseases including eye diseases, diabetes, autism spectrum disorder and mesiodens \[[@CR14], [@CR19]--[@CR21]\]. Variants of *PAX6* are correlated with eye diseases and the insulin response \[[@CR22]--[@CR24]\]. Lei HH et al. identified that variants of rs667773 and rs3026393, and showed that the GG genotype of rs302693 was less prevalent in 20 patients with mesiodens than in 31 controls \[[@CR18]\]. These results were further supported by our study. Polymorphisms in rs667773 and rs3026393 of *PAX6* were detected in the current study, and the mesiodens group might have fewer genotypes of GG (rs3026393) than do the controls. Polymorphisms related to other diseases were not detected in this study; however, this may be because the patients with mesiodens did not have any other diseases.

Mesiodens is the most common type among supernumerary teeth, and the development of supernumerary teeth is closely associated with bone morphogenetic protein (*BMP*) and Wnt signaling pathways \[[@CR25]\]. *BMP* is required for *SHH* expression during early tooth development and postnatal root development \[[@CR26]\]. However, *SOSTDC1* is an inhibitor of *BMP*, and the deletion of *SOSTDC1* in mice induces the formation of mesiodens \[[@CR15]\]. *Wnt*, another signaling pathway, can be inhibited by *SOSTDC1*, located in the upstream of Sonic hedgehog (Shh), and induces the expression of Shh, followed by the induction of high *SOSTDC1* expression. Insufficient *SOSTDC1* enhances WNT signaling, which increases proliferation and continuous development of vestigial tooth buds and results in the formation of supernumerary teeth \[[@CR27], [@CR28]\]. In our study, two polymorphisms (rs6945425 and rs12699799) were detected in *SOSTDC1*, but none of them were found related to susceptibility to mesiodens.

FAM20B is a member of Family with sequence similarity 20 (Fam20) proteins containing FAM20A, FAM20B, and FAM20C in the human genome \[[@CR29]\]. *FAM20A* knockout mice have biomineralization defects, and mutations in *FAM20A* have been found to be associated with amelogenesis imperfecta subsequently \[[@CR30]--[@CR32]\]. *FAM20B* null mice showed mesiodens \[[@CR15]\]; however, the relationship between variants of *FAM20B* and mesiodens has not yet been reported. Our results suggest for the first time that individuals with T allele of *FAM20B* (rs3766626) appear to have a low risk of mesiodens, which was located in the 3′ untranslated region (3′ UTR) of corresponding gene. Although it isn't translated into protein, previous and recent studies showed that variant in 3′ UTR region could impact the expression of mRNA \[[@CR33], [@CR34]\].

The current study provides information on the association between genetic polymorphisms and the occurrence of mesiodens; however, there are some limitations. The sample size (mainly the control size) and the number of genes analyzed in this study were limitations. The mechanism by which these polymorphism affect mesiodens is unknown. Further studies including more samples, more genes, and the mechanism of these polymorphism on mesiodens are needed.

Conclusions {#Sec11}
===========

There were no significant differences of *PAX6*/*SOSTDC1*/*FAM20B* gene polymorphisms between the two groups. Further studies with large samples on T allele of *FAM20B* (rs3766626) are needed.

Additional files
================

 {#Sec12}

Additional file 1:The amplification sequences of *FAM20B*. (DOCX 22 kb) Additional file 2:The amplification sequences of *SOSTDC1*. (DOCX 13 kb)
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